"why they didn't decide then and there to wind up the company"
asx it was just before Lee Rodne's resignation that the company outlined its "Building out portfolio of adapt related products for large markets". This included - Aortic Heart valve reconstruction study and Adapt vessels "for off the shelf" vessel repairs including in CABG among others. It has been a long and at times stressful period for some investors but I would like to think that we are finally getting very close to completing those two projects and that it will provide a better return to shareholders than a winding up would have back in 2016.
Ann: Trading Halt, page-76
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$11.85 |
Change
-0.150(1.25%) |
Mkt cap ! $249.8M | |||
| Open | High | Low | Value | Volume |
| $11.88 | $12.00 | $11.50 | $210.4K | 17.80K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 460 | $11.85 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $11.98 | 408 | 5 |
View Market Depth
| Last trade - 13.52pm 09/10/2024 (20 minute delay) ? |
| AVR (ASX) Chart |